Drug name - Lyvispah

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10792262 AMNEAL Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives Jul, 2039

(16 years from now)

Drugs and Companies using BACLOFEN ingredient

Treatment: Method for treating spasticity

Dosage: GRANULES;ORAL

More Information on Dosage
Strength Dosage Availability
5MG/PACKET GRANULES;ORAL Prescription
10MG/PACKET GRANULES;ORAL Prescription
20MG/PACKET GRANULES;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.